Transmitter‐Like Basal and K+‐Evoked Release of 3,4‐Dihydroxyphenylalanine from the Striatum in Conscious Rats Studied by Microdialysis
- 1 January 1992
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 58 (1) , 270-275
- https://doi.org/10.1111/j.1471-4159.1992.tb09306.x
Abstract
Using microdialysis and HPLC, characteristics of the release of endogenous 3,4‐dihydroxyphenylalanine (DOPA) from striatum in conscious rats were studied in comparison with those of 3,4‐dihydroxyphenylethylamine (dopamine; DA). Purified l‐aromatic amino acid decarboxylase (AADC) converted a putative peak of DOPA to DA. The retention time of DOPA differed from that of DA and major metabolites of DA and norepinephrine. The DOPA peak of dialysates comigrated with that of authentic DOPA when the pH of the HPLC buffer was modified. The ratio of the basal release of DOPA:DA was 1:2. 3‐Hydroxybenzyl‐hydrazine (NSD‐1015; 100 mg/kg, i.p.), an AADC inhibitor, markedly increased the basal release of DOPA but produced no effect on DA. The basal release of DOPA was markedly decreased by α‐methyl‐p‐tyrosine (200 mg/kg, i.p.), substantially tetrodotoxin (1 μM) sensitive, and Ca2+ (removal plus 12.5 mM Mg2+ addition) dependent. Fifty millimolar K+ released DOPA and this release was also Ca2+ dependent. These characteristics of the basal and evoked release of DOPA were similar to those of DA. The ratio of the evoked release of DOPA:DA was 1:3. These results indicate that DOPA is released under physiological conditions and by K+‐induced depolarization in a manner similar to that for transmitter DA from striatum in freely moving rats.Keywords
This publication has 23 references indexed in Scilit:
- Nanomolar L-DOPA facilitates release of dopamine via presynaptic .BETA.-adrenoceptors: Comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-treated C57 black mice, an animal model for parkinson's disease.The Japanese Journal of Pharmacology, 1991
- Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonismBrain Research, 1990
- L-DOPA Facilitates the Release of Endogenous Norepinephrine and Dopamine via Presynaptic β- and β-Adrenoceptors under Essentially Complete Inhibition of L-Aromatic Amino Acid Decarboxylase in Rat Hypothalamic SlicesThe Japanese Journal of Pharmacology, 1990
- L-DOPA methyl ester antagonizes competitively L-DOPA-induced facilitation of noradrenaline release from rat hypothalamic slices.The Japanese Journal of Pharmacology, 1990
- Endogenous l-DOPA, its immunoreactivity in neurons of midbrain and its projection fields in the catNeuroscience Letters, 1988
- Transmitter‐Like Release of Endogenous 3,4‐Dihydroxyphenylalanine from Rat Striatal SlicesJournal of Neurochemistry, 1988
- A nonisotopic method for determination of the in vivo activities of tyrosine hydroxylase in the rat adrenal glandAnalytical Biochemistry, 1988
- Biphasic actions of L‐DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slicesBritish Journal of Pharmacology, 1986
- Aromaticl-amino acid decar☐ylase in the rat brain: Immunocytochemical localization in neurons of the brain stemNeuroscience, 1984
- Tyrosine hydroxylase activation in depolarized dopaminergic terminals—involvement of Ca2+ -dependent phosphorylationNature, 1983